Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-01

Clinical Trial Update: Efficacy of Soluble Dexamethasone in Refractory Sciatica [Phase 3]

View source ↗

Summary

Phase 3 trial investigating soluble dexamethasone for refractory sciatica has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Soluble Dexamethasone (dexamethasone)

Snippet

Sponsor: Nantes University Hospital | Conditions: Sciatica | Phase 3 | Status: COMPLETED